Bridge notes amortization schedule
Company: Core Scientific
What the later record shows
Outcome not yet confirmed
Later filings restate that principal payments were moved into the first half of 2023. None says whether the installments through May 2023 were actually paid.
“Under the terms of the modified agreement, $37.5 million of principal payments previously due in the second half of 2022 are now due in the first half of 2023.”
2024-05-05 · Core Scientific 424B3 filed 2024-05-06 View cached copy (2026-08-31)Live source ↗
Checked October 10, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.
The claim, verbatim
The bridge notes amortize through May 2023 with scheduled monthly payments totaling $75 million, with payments ranging from $4.875 million to $18 million per installment
Source (primary)
Core Scientific 8-K filed 2022-08-04 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “The Notes bear interest at a rate of 7% per annum and amortize collectively as follows: Payment Dates Payment Amount August 1, 2022 $ 18,000,000 September 1, 2022 $ 4,875,000 October 1, 2022 $ 4,875,000 November 1, 2022 $ 4,875,000 December 1, 2022 $ 4,875,000 January 1, 2023 $ 6,250,000 February 1, 2023 $ 6,250,000 March 1, 2023 $ 6,250,000 April 1, 2023 $ 6,250,000 May 1, 2023 $ 6,250,000”
How we checked this
Checked on October 11, 2026. The cited source supports part of this claim, but not all of it.
The filing's schedule confirms the monthly payment dates and the $4.875 million to $18 million range. However, the listed payments add up to $68.75 million, not $75 million.
Confirmed in the source:
- The bridge notes amortize in scheduled monthly payments from August 1, 2022 through May 1, 2023
- Individual installments range from $4.875 million to $18 million
We could not confirm this from the cited source:
- The scheduled amortization payments total $75 million (the listed payments sum to $68.75 million)
That does not mean it is false — only that this source does not establish it, as of the date above. If we find a source that settles it, we will re-check and update this page.
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000119312522212538/d373174d8k.htm) in full (7,649 characters, retrieved September 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific 8-K filed 2022-08-04
Quote: “The Notes bear interest at a rate of 7% per annum and amortize collectively as follows: Payment Dates Payment Amount August 1, 2022 $ 18,000,000 September 1, 2022 $ 4,875,000 October 1, 2022 $ 4,875,000 November 1, 2022 $ 4,875,000 December 1, 2022 $ 4,875,000 January 1, 2023 $ 6,250,000 February 1, 2023 $ 6,250,000 March 1, 2023 $ 6,250,000 April 1, 2023 $ 6,250,000 May 1, 2023 $ 6,250,000”